Boris Johnson said the NHS will be the “top priority” for his government after the Conservative's sweeping victory.
Four-fifths of pharmacists are facing “overwhelming” workplace pressures, a survey of the profession indicates.
EHC should be reclassified as GSL and “sold off the shelf without consultation,” the RCOG has said.
NPA, PSNC and the RPS launch the Community Pharmacy Manifesto.
RPS president Sandra Gidley said her views on pharmacy technician membership have “changed considerably".
The framework outlines the capabilities needed for foundation pharmacists to provide increasingly complex clinical care.
Pharmacists in England are to be reimbursed for dispensing cannabis-based products for the first time.
More vaccinations should be provided in convenient locations for parents to drive uptake, says a new NHS review.
The RPS calls on the government to ensure all pharmacists have access to NHS-funded mental health support services.
Pharmacists have been granted powers to dispense an “alternative strength or pharmaceutical form” of fluoxetine.
The NAWP – which had announced plans to dissolve – is to continue as part of the PDA from the beginning of next year.
Labour's plans would bring England in line with Wales, Scotland and Northern Ireland.
Community pharmacies are more likely to fail a GPhC inspection but also account for all pharmacies rated excellent.
The GPhC said this would improve transparency and “drive improvement in pharmacy services.”
The early career report was commissioned by the Association of Pharmacy Technicians UK and Health Education England.
Social deprivation and lack of access to information are potential factors in prescription drug dependence.
The RPS, BMA and RCGP have called for the greater use of community pharmacists across primary care networks.
The government must take a long-term approach to the recruitment and training of pharmacists, the RPS tells Sajid Javid.
The first details have been released about the Community Pharmacist Consultation Service.
In a letter to Boris Johnson, health bodies said they were “unable to reassure patients" that Brexit wouldn't affect them.
